Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients

SIMPLE SUMMARY: Prostate cancer (PCa) is the most commonly diagnosed non-skin cancer in men and one of the leading causes of cancer-related death. The driver of PCa proliferation and growth is the androgen receptor (AR) and inhibiting this receptor is the standard of care for patients, following sur...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Lallous, Nada, Snow, Oliver, Sanchez, Christophe, Parra Nuñez, Ana Karla, Sun, Bei, Hussain, Ahmed, Lee, Joseph, Morin, Helene, Leblanc, Eric, Gleave, Martin E., Cherkasov, Artem
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2021
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230763/
https://ncbi.nlm.nih.gov/pubmed/34208290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122939
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk